GENinCode (LON:GENI) Trading 110.2% Higher – Here’s What Happened

GENinCode Plc (LON:GENIGet Free Report) shares shot up 110.2% on Thursday . The company traded as high as GBX 6.95 ($0.09) and last traded at GBX 6.73 ($0.08). 7,091,908 shares were traded during trading, an increase of 1,322% from the average session volume of 498,732 shares. The stock had previously closed at GBX 3.20 ($0.04).

GENinCode Stock Performance

The company’s 50-day simple moving average is GBX 3.80 and its 200-day simple moving average is GBX 5.16. The stock has a market capitalization of £11.97 million, a price-to-earnings ratio of -135.32 and a beta of 0.66. The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.